Strong leadership and governance are keys to long-term success at Sensient. The Board is the principal governance and oversight body. The key responsibilities of the Board include approving long-term strategy, protecting and enhancing the Sensient brand, and approving policies and regulations. The Board includes the Chairman and ten directors. Officers of Sensient are the employees elected by the board to provide day-to-day leadership to the organization.

50/50 Women on Boards™ recognizes Sensient Technologies as a “3+” company for having three or more women on its corporate board of directors.

Dr. Joseph Carleone

Independent Lead Director
Member of Audit, Executive, and Scientific Advisory Committees

Dr. Carleone is Chairman of the Board of AMPAC Fine Chemicals LLC, a leading manufacturer of pharmaceutical active ingredients (since December 2015). Prior to this position, Dr. Carleone was President and Chief Executive Officer of American Pacific Corporation (from 2010 to 2015), a leading custom manufacturer of fine and specialty chemicals and propulsion products, and a director of American Pacific Corporation (from 2006 to 2015). Dr. Carleone was Chairman of the Board of American Pacific Corporation from March 12, 2013, until it was acquired by H.I.G. Capital, LLC, on February 27, 2014, and President and Chief Operating Officer of American Pacific Corporation from 2006 to 2009. Dr. Carleone has also served or currently serves as an officer and/or a director of several directly or indirectly wholly-owned subsidiaries of American Pacific Corporation. From 2007 through 2009, Dr. Carleone served as a director for Reinhold Industries, Inc., a diversified manufacturer of advanced custom composite components and sheet molding compounds for a variety of applications in the United States and Europe. From 2005 through 2006, Dr. Carleone served as Senior Vice President and Chief Product Officer of Irvine Sensors Corporation, a technology company engaged in the design, development, manufacture and sale of security products, software, vision systems and miniaturized electronic products and higher level systems for defense, information technology and physical security for government and commercial applications. From 2003 through 2005, he served as a member of the board of directors of Irvine Sensors Corporation. Dr. Carleone also served as President of Aerojet Fine Chemicals LLC, a business unit of GenCorp Inc., and as Vice President of GenCorp Inc., a manufacturer of aerospace and defense products and systems with a real estate segment, from 2000 to 2005. From 1999 to 2000, he was Vice President and General Manager of Remote Sensing Systems at Aerojet. In addition, he served as Vice President, Operations at Aerojet from 1997 to 2000.

Dr. Carleone received his bachelor’s degree in Mechanical Engineering from Drexel University, Philadelphia, Pennsylvania, in 1968; his masters’ degree in Applied Mechanics from Drexel University in 1970; and his doctorate degree in Applied Mechanics from Drexel University in 1972.

Dr. Mario G. Ferruzzi

Member of Compensation & Development, Nominating & Corporate Governance, and Scientific Advisory Committees

Dr. Ferruzzi is a Professor in the Plants for Human Health Institute and the Department of Food, Bioprocessing and Nutrition Science at North Carolina State University. Prior to joining North Carolina State University, Dr. Ferruzzi most recently served as a Professor in the Department of Food Science at Purdue University (2004-2016), a Research Scientist in the Coffee and Tea Beverage Development group at Nestlé Research & Development Center, Marysville, Ohio, and a Research Scientist at the Nutrition & Health and Scientific & Nutritional Support Departments at the Nestlé Research Centre in Lausanne, Switzerland. He received his B.S. in Chemistry from Duke University (1996) and his M.S. (1998) and Ph.D. (2001) in Food Science and Nutrition from The Ohio State University.

Dr. Ferruzzi is recognized for his expertise in analytical chemistry and its applications to food and nutrition research. His core research interests are in the area of botanical chemistry with emphasis on investigating the impact of the food matrix and processing on the stability, bioavailability and metabolism of health promoting phytochemicals and micronutrients. Dr. Ferruzzi’s research has been consistently funded by federal agencies including the U.S. Department of Agriculture, the National Institutes of Health and the United States Agency for International Development as well as the food industry. His core activities in food chemistry, food processing and translational nutrition have resulted in over 120 publications as well as extensive national and international research collaborations and activities.

For his research efforts Dr. Ferruzzi has received awards from the Institute of Food Technologist (2010 Samuel Cate Prescott Young Investigator Award), the American Society for Nutrition (2011 Mary Rose Swartz Young Investigator Award), Purdue University (2012 Agricultural Research Award) and was named a University Faculty Scholar by Purdue University in 2013.

Dr. Ferruzzi has served as a scientific advisor to several food manufacturers and associations and is a member of the Board of Trustees for the North America branch of the International Life Science Institute. He is a professional member of the Institute of Food Technologist (IFT), the American Society for Nutrition (ASN), the American Chemical Society (ACS) and a Fellow of the Royal Society of Chemistry. Dr. Ferruzzi has held multiple leadership roles in these societies, most notably IFT and ASN at both local and national levels. He served as Chair of the Food Science & Nutrition Solutions Taskforce, a joint working group between IFT-ASN-IFIC and the Academy of Nutrition and Dietetics (AND). Additionally, Dr. Ferruzzi serves on the editorial boards of Nutrition Research, Nutrition Today, Critical Reviews in Food Science and Nutrition and as Associate Editor for the Royal Society of Chemistry’s journal Food & Function.

Carol R. Jackson

Member of Audit, Nominating & Corporate Governance, and Scientific Advisory Committees

Ms. Jackson is Chairman, President, and Chief Executive Officer of Harbison Walker International, the largest supplier of ceramic refractories in the U.S. with operations in the U.S., Mexico, Europe, and Southeast Asia and commercial interests globally. Harbison Walker is a 150-year-old private company that generates revenues of between $500 million to $1 billion annually. She previously served as Corporate Officer, Senior Vice President, and General Manager at Harbison Walker.

Prior to joining Harbison Walker in 2014, Ms. Jackson held a number of senior corporate and management roles at Carpenter Technology Corporation (2011-13) and PPG Industries (1999-2011). Ms. Jackson holds a B.S. in Business Administration from Duquesne University, an MBA from Carnegie Mellon University, and a Juris Doctorate from the University of Pittsburgh.

Ms. Jackson is a licensed attorney. Since 2014, she has been a Director and Member of the Governance Committee of Junior Achievement of Western Pennsylvania.

Sharad P. Jain

Member of Audit, Finance, and Scientific Advisory Committees

Mr. Jain has more than 33 years of experience providing audit and audit-related services to large global companies with the international accounting firm PricewaterhouseCoopers (he retired from the firm in 2020). His experience includes service as the Global and US Automotive Assurance Sector Leader from 2012 until 2015, and service as a senior partner in the firm’s Governance Insights Center from 2018 until 2020. He also led the firm’s Consumer and Industrial Products Assurance teams in Detroit and Chicago and served on the firm’s Global Auditing Committee, which oversees the quality and consistency of the firm’s global audit methodology and tools.

Mr. Jain is a Certified Public Accountant, recipient of the Elijah Watt Sells Award, and was trained as a Chartered Accountant in the UK before moving to the USA with PricewaterhouseCoopers.

Mr. Jain will serve on the Audit, Finance, and Scientific Advisory Committees of the Board.

Dr. Donald W. Landry

Member of Compensation & Development, Nominating & Corporate Governance (Chairman), and Scientific Advisory Committees

Dr. Landry is the Samuel Bard Professor and Chair of the Department of Medicine (tenured) at Columbia University’s College of Physicians and Surgeons. He also serves as its Director of the Division of Experimental Therapeutics and Physician-in-Chief for the Medical Service at New York Presbyterian Hospital/Columbia Medical Center. Dr. Landry has been a member of the faculty of Columbia University since 1985. At Columbia, Dr. Landry developed the first artificial enzyme to degrade cocaine and his report in Science was voted one of top 25 papers in the world for 1993 by the American Chemical Society. His discovery that vasopressin can be used to treat vasodilatory shock fundamentally changed intensive care medicine. He also pioneered an embryo-sparing approach to the generation of human embryonic stem cells.

Dr. Landry has been a Director of Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) since October 2011. Between June 2007 and October 2011, Dr. Landry served as a founding director of Tonix Pharmaceuticals, Inc., a wholly-owned subsidiary of Tonix Pharmaceuticals Holding Corp. Tonix Pharmaceuticals is a publicly traded company that develops next-generation medicines for common disorders of the central nervous system, including fibromyalgia, post-traumatic stress disorder and episodic tension-type headache.

Dr. Landry was co-founder and has been a member of L&L Technologies LLC since 1996. L&L Technologies LLC was formed to develop medications for central nervous system conditions. Dr. Landry was also a co-founder of Vela Pharmaceuticals, which developed several drugs for central nervous system disorders, including very low dose (VLD)-cyclobenzaprine for fibromyalgia syndrome.

Dr. Landry established his laboratory at Columbia University in 1991 to investigate medical applications of artificial enzymes and in 1998 founded the Division of Experimental Therapeutics. The Division focuses on novel therapeutics for intractable problems such as cocaine addiction, nerve gas intoxication and vasodilatory shock. Dr. Landry is a leader in the ethical development of embryonic stem cells and served as a member of the President’s Council on Bioethics during the George W. Bush administration. In 2008, Dr. Landry was awarded the Presidential Citizens Medal, the nation’s second-highest civilian award.

Dr. Landry graduated from Lafayette College, completed his Ph.D. in organic chemistry under Nobel laureate R.B. Woodward at Harvard University in 1979 and then obtained his M.D. degree from Columbia University’s College of Physicians and Surgeons in 1983. After residency in Internal Medicine at the Massachusetts General Hospital, he returned to Columbia University as a National Institutes of Health (NIH) Physician-Scientist, 1985-1990. Dr. Landry has published 106 peer-reviewed articles, authored 31 review articles or book chapters and holds 34 patents as inventor or co-inventor.

Paul Manning

Chairman of the Board, President and Chief Executive Officer
Member of Executive (Chairman), Finance, and Scientific Advisory Committees

Mr. Paul Manning has been Sensient’s Chairman, President and Chief Executive Officer since April 21, 2016. He joined the Company in 2009 as General Manager, Food Colors North America, and became President of the Color Group in 2010. He became President and Chief Operating Officer of the Company in October 2012, and President and Chief Executive Officer in February 2014. Before joining the Company, he worked for Danaher Corporation as Mergers and Acquisitions Integration Manager of the Fluke Division and he held various supply chain and project manager positions with McMaster-Carr Supply Company. He holds a B.S. degree in Chemistry from Stanford University and an MBA from Northwestern University. He attended Stanford University on a Naval ROTC scholarship and served in the U.S. Navy as a Surface Warfare Officer for four years.

During his four years of working within and then running the Color Group, Mr. Manning gained a thorough understanding of both the opportunities and the challenges facing the Company’s Color businesses and made critical contributions to its improved performance. As the Company’s President and Chief Operating Officer, his management skills and experience allowed him to make similar contributions in the Company’s other businesses, including his critical role in the relocation of the Flavors & Fragrances Group headquarters from Indianapolis to the Chicago area on time and on budget. In his current position as the Company’s Chairman, President and Chief Executive Officer, he has been responsible for the continued success of the Company, including its strong profits and sales, ongoing restructuring activities in the Flavors & Fragrances Group, upgrading of sales force and general manager talent, leading the Board of Directors and articulating and executing the Company’s strategy.

Deborah McKeithan-Gebhardt

Member of Finance (Chairman), Nominating & Corporate Governance, and Scientific Advisory Committees

Ms. McKeithan-Gebhardt is President and Chief Operating Officer of Tamarack Petroleum Company, Inc. (since 2009), and also serves as Chief Executive Officer of Tamarack River Resources, LLC (since 2009). She previously served as Vice President and General Counsel of Tamarack Petroleum Company, Inc. (from 1991 to 2009). Tamarack Petroleum Company, Inc. is a private company engaged in oil and gas exploration. Tamarack River Resources, LLC is a Delaware limited liability company of which Tamarack Petroleum Company, Inc., is the majority member. Ms. McKeithan-Gebhardt has been with Tamarack Petroleum since 1991. Prior to joining Tamarack Petroleum, she was an attorney in private practice.

As President and Chief Operating Officer, and previously as Vice President and General Counsel of Tamarack Petroleum Company, Inc., Ms. McKeithan-Gebhardt has primary responsibility for and extensive experience in a range of strategic and operational matters, including human resources, compensation and employee benefits, financial management and reporting, regulatory and compliance, legal affairs and risk management.

Ms. McKeithan-Gebhardt earned a bachelor of arts degree in Business Administration from Cardinal Stritch University in 1980 and a Juris Doctorate degree summa cum laude from Marquette University Law School in 1987. Ms. McKeithan-Gebhardt currently serves as a member of the Marquette University Law School Advisory Board.

Scott Morrison

Member of Audit, Compensation & Development (Chairman), and Scientific Advisory Committees

Mr. Morrison is Senior Vice President and Chief Financial Officer of Ball Corporation, a leading global supplier of innovative, sustainable packaging solutions for beverage, food and household products customers. He previously served as Vice President and Treasurer of Ball Corporation. Prior to joining Ball Corporation, Mr. Morrison held senior corporate banking roles at Bank One, First Chicago and NBD Bank, Detroit.

Mr. Morrison is an Executive Committee Member of the Board for the National Association of Manufacturers and Community Chairman of the Denver Chapter of the Kelley School of Business Indiana University. He previously served as Chairman of the National Association of Corporate Treasurers and as an expert testimony witness to the U.S. House of Representatives Agricultural Committee on Dodd Frank legislation. Mr. Morrison has been recognized as CFO of the Year by CFO Magazine and Institutional Investor.

Mr. Morrison received his Bachelor’s Degree (1984) in Finance from Indiana University and his M.B.A. (1988) from Wayne State University.

Dr. Elaine R. Wedral

Member of Compensation & Development, Executive, Finance, and Scientific Advisory Committees (Chairman)

Dr. Wedral has served as President of the International Life Sciences Institute-North America, a nonprofit organization based in Washington, D.C., that provides a forum for academic, government and industry scientists to identify important nutrition and food safety issues and works toward solutions for the benefit of the general public. From 2003 to 2014, Dr. Wedral was also a director of Balchem Corporation (where she served as chair of the governance and nominating committee and a member of the compensation committee), which is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. Dr. Wedral also serves on the editorial board of Food Processing magazine, serves on the board of the Women’s Global Health Institute at Purdue University and continues to work with several industry groups and universities on food science issues in an advisory capacity. Dr. Wedral works closely with management on the Company’s Chemical Risk Reduction Strategy.

Dr. Wedral holds a B.S. degree in Biochemistry from Purdue University, an M.S. degree in Food Microbiology from Cornell University and a Ph.D. in Food Biochemistry from Cornell University. From 1972 to 2006, Dr. Wedral served in various capacities with the Nestle Company, including as President of Nestle R&D Center, Inc., and director of Nestle R&D Food Service Systems Worldwide from 2000 to 2006 and as President of all Nestle U.S. R&D Centers from 1988 to 1999. During her tenure with Nestle, Dr. Wedral developed the strategy and accompanying R&D program for its foodservice systems. Among other things, she was responsible for the reorganization and supervision of Nestle’s existing R&D facilities in North America, with over 700 personnel, and the development, construction and management of a new state-of-the-art pet food and nutrition facility, a new beverage, confection and ice cream facility and renovation of a consolidated food and nutrition laboratory, each combining an emphasis on proprietary innovation with production efficiencies and commercialization opportunities.

Dr. Wedral holds over 38 U.S. and European patents in food science, chemistry and food service systems to deliver foods and beverages, most related to food flavors and colors and food fortifications (e.g., adding bioavailable iron to fortify a product without discoloring it). Dr. Wedral’s work often helped create new product categories (e.g., shelf-stable liquid coffee creamers and refrigerated pizzas) while emphasizing food safety and quality. Dr. Wedral also has experience and expertise in helping to commercialize food and beverage products and delivery systems designed for local tastes and preferences around the world.

Essie M. Whitelaw

Member of Audit, Compensation & Development, Executive, and Scientific Advisory Committees

Ms. Whitelaw served as Senior Vice President of Operations of Wisconsin Physician Services, a provider of health insurance and benefit plan administration, from 2001 until her retirement in 2010, where she was responsible for managing more than 430 employees. Before that, Ms. Whitelaw served more than 15 years in various executive positions, including as President and Chief Operating Officer (1992 to 1997) and Vice President of National Business Development at Blue Cross Blue Shield of Wisconsin, a comprehensive health and dental insurer. Among other things, while at Blue Cross Blue Shield, Ms. Whitelaw was responsible for managing insurance risk underwriting activities, regulatory compliance and the development and implementation of appropriate sales incentive programs. Prior to its merger into another public utility in 2000, Ms. Whitelaw served on the board and on the audit, nominating and retirement plan investment committees of WICOR Corporation, a Wisconsin energy utility.

Ms. Whitelaw is active in the local Wisconsin community. She currently serves on the Milwaukee Public Museum board of directors, the Wisconsin Lutheran Foundation board, the Atonement Lutheran School board and the board of the Wisconsin Women’s Health Foundation, a nonprofit organization dedicated to improving the health and lives of women and their families through education, outreach programs and partnerships. Ms. Whitelaw’s prior board service includes Goodwill Industries, United Way of Greater Milwaukee, Blue Cross Blue Shield Foundation, Metropolitan Milwaukee Association of Commerce, Greater Milwaukee Committee and Bradley Center Sports and Entertainment Corporation.

Paul Manning

Chairman of the Board, President and Chief Executive Officer

Paul Manning joined Sensient in June 2009 as General Manager, Food Colors North America. His responsibility expanded to include all of Latin and South America. He also assumed responsibility for pharmaceutical, industrial colors and inkjet colors. He was elected to the position of President, Color Group in July 2010. In October 2012, he was elected to the position of President and Chief Operating Officer. He was also elected to the Board of Directors. In February 2014, Paul was elected as Chief Executive Officer of Sensient Technologies Corporation.

Prior to joining Sensient, Paul Manning was employed by the Fluke Corporation (Danaher) in mergers and acquisitions integration management and at McMaster-Carr Supply Company in various supply chain management and project management roles. He has also served as a US Navy Surface Warfare Officer.

Paul Manning holds a Bachelor of Science degree in Chemistry from Stanford University and an MBA from the Kellogg School of Management at Northwestern University.

Amy M. Agallar

Vice President and Treasurer

Amy M. Agallar joined Sensient in January 2019 as Vice President and Treasurer. Prior to joining Sensient, she served in various financial, accounting, and managerial roles with Modine Manufacturing Company, including Director – Business Development CIS, and Director – Global Treasury Operations.

Ms. Agallar received her bachelor’s degree in finance and MBA from the University of Wisconsin – Parkside.

Michael C. Geraghty

President, Colors Group

Michael Geraghty joined Sensient as General Manager, Food Colors USA, in April 2011. He was elected to the position of President, Colors Group, in October 2012.

Prior to joining the company, Mr. Geraghty founded Ready Solutions Incorporated and managed it for seven years. He also has held managerial positions in GE Plastics and Calgon Corporation.

Mr. Geraghty holds a bachelor of chemical engineering degree from Villanova University and an MBA from Jacksonville University.

Thierry Hoang

Vice President, Asia Pacific Group

Thierry Hoang joined Sensient in 2009 and has previously served as a General Manager, Business Unit Manager, and Sales Account Manager for Sensient Cosmetics in France and Asia Pacific. He was elected to the position of Vice President, Asia Pacific Group in June 2018.

Prior to joining Sensient, Mr. Hoang worked as an Assistant Product Manager at Mayoly Spindler.

Mr. Hoang received his master’s degree in biochemistry from Paris-Sud University and his master’s degree in sales and marketing from Paris Dauphine University.

Amy Schmidt Jones

Vice President, Human Resources and Senior Counsel

Amy Schmidt Jones joined Sensient in April 2018 as Vice President, Human Resources and Senior Counsel. Prior to joining Sensient, she was a partner of Michael Best & Friedrich LLP and chaired the firm’s Labor & Employment Relations Practice Group.

Ms. Jones received her bachelor’s degree, magna cum laude, in Government and Psychology from Georgetown University. She received her juris doctor, magna cum laude, from the New York University School of Law.

John J. Manning

Senior Vice President, General Counsel and Secretary

John Manning joined Sensient in January 2013 as Vice President and Assistant General Counsel.

Prior to joining Sensient, John Manning was Deputy Criminal Chief for the United States Attorney’s Office – Eastern District of Wisconsin. He previously served as a line Assistant United States Attorney in Milwaukee and Washington, D.C., and tried more than 40 criminal cases to verdict. Prior to becoming a prosecutor, John Manning was a litigation associate with Collier, Shannon, Rill & Scott in Washington, D.C.

John Manning received his bachelor’s degree, with distinction, in history from Stanford University. He received his juris doctor, magna cum laude, from Georgetown University Law Center. Before attending law school, John Manning served for four years as a Surface Warfare Officer in the United States Navy.

E. Craig Mitchell

President, Flavors and Extracts Group

E. Craig Mitchell joined Sensient in September 2018 as President, Flavors and Extracts Group. Prior to joining Sensient, he served as President and Chief Operating Officer of Sekisui Specialty Chemicals America, LLC, as Vice President of Sales, Americas of Celanese Corporation, and in various other leadership and managerial roles with Ashland Inc., Celanese Corporation, and Nalco Chemical Company (now known as Nalco Water, an Ecolab Company).

Mr. Mitchell received his bachelor’s degree in chemical engineering from the University of Southern Alabama.

Stephen J. Rolfs

Senior Vice President and Chief Financial Officer

Stephen Rolfs joined Sensient in 1997 as Manager, Corporate Development. In his 22 years with the Company, Mr. Rolfs has served in several Executive Officer positions in the areas of Corporate Development, Administration, Accounting and Treasury. Mr. Rolfs served as Sensient’s Vice President, Corporate Controller and Chief Accounting Officer from 2001 to 2010. In February of 2015, Mr. Rolfs was promoted to the position of Senior Vice President and Chief Financial Officer.

Prior to joining Sensient, Mr. Rolfs was employed by Brown-Forman Corporation, a beverage and consumer products company, as a financial analyst and as Assistant Vice President. From 1986 to 1991 he worked as a CPA for the public accounting firm of Ernst & Young.

Mr. Rolfs holds a bachelor's degree in accounting from the University of Notre Dame and an MBA from the University of Chicago.

Tobin Tornehl

Vice President, Controller and Chief Accounting Officer

Mr. Tornehl joined Sensient in 2008 as Director of Finance. In November 2018, he was elected to the position of Vice President, Controller and Chief Accounting Officer.

Prior to joining Sensient, Mr. Tornehl worked as an accountant at Ernst & Young for four years and then in various finance positions within Strong Capital Management and Jefferson Wells.

Mr. Tornehl is a Certified Public Accountant. He received a bachelor’s degree in accounting from Boston College.